1. Home
  2. SNY vs MDT Comparison

SNY vs MDT Comparison

Compare SNY & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$49.34

Market Cap

119.4B

Sector

Health Care

ML Signal

HOLD

Logo Medtronic plc.

MDT

Medtronic plc.

HOLD

Current Price

$101.49

Market Cap

114.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNY
MDT
Founded
1994
1949
Country
France
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.4B
114.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SNY
MDT
Price
$49.34
$101.49
Analyst Decision
Buy
Buy
Analyst Count
4
18
Target Price
$61.50
$108.63
AVG Volume (30 Days)
2.3M
7.9M
Earning Date
10-24-2025
11-18-2025
Dividend Yield
3.23%
2.80%
EPS Growth
105.93
12.98
EPS
8.67
3.69
Revenue
$53,890,648,839.00
$34,758,000,000.00
Revenue This Year
$2.37
$8.60
Revenue Next Year
$6.51
$5.83
P/E Ratio
$11.25
$27.47
Revenue Growth
N/A
5.34
52 Week Low
$44.62
$79.29
52 Week High
$60.12
$106.33

Technical Indicators

Market Signals
Indicator
SNY
MDT
Relative Strength Index (RSI) 46.53 59.12
Support Level $48.89 $101.58
Resistance Level $50.43 $105.73
Average True Range (ATR) 0.73 1.90
MACD -0.15 -0.03
Stochastic Oscillator 19.29 52.85

Price Performance

Historical Comparison
SNY
MDT

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About MDT Medtronic plc.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Share on Social Networks: